Drugstore welcomes the most strict supervision! 1. Violation of regulations or joint sitting
-
Last Update: 2020-02-21
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On January 22, the State Medical Security Bureau issued the Interim Measures for the designated management of medical security of retail pharmacies (Draft for comments) (hereinafter referred to as the draft for comments), which formally solicited opinions from the public >>Article 42 suspension of designated service agreement means that the agency and designated retail drugstore suspend the performance of the agreement, and the medical insurance expenses incurred during the suspension period will not be settled At the end of the suspension period, the agreement can continue to be performed The service agreement shall not be suspended for more than 6 months, which shall be deemed as the termination of the service agreement In case of any of the following circumstances, the service agreement may be terminated: (XIV) if one of the chain retail drugstores in the same overall planning area is terminated due to violating the relevant provisions of medical insurance, the other chain drugstores of the same legal person shall be terminated at the same time It is not difficult to understand that strict management and upgrading is intended to strengthen the awareness of the business subject to strictly abide by the bottom line, and put an end to damaging the health insurance fund from the source According to the 2018 national basic medical security development statistics bulletin (hereinafter referred to as the bulletin) released by the state health insurance bureau, during the special action against fraud and deception of medical security fund in 2018, 197000 designated medical institutions and retail pharmacies were inspected nationwide, and 66000 designated medical institutions were investigated and dealt with in violation of laws and regulations, accounting for about one-third of the selected institutions, accounting for all the designated institutions One ninth of the medical institutions, including 1284 medical insurance agreements were terminated, 127 were transferred to the judiciary, and 24000 people were investigated and punished for violating laws and regulations In 2019, the fight against fraud and medical insurance fraud has been upgraded again On August 12, 2019, the general office of the State Council issued the plan for the division of key tasks of the national deepening of the reform of "management service" and optimizing business environment teleconference (hereinafter referred to as the plan) According to the plan, "the national health insurance bureau is responsible for carrying out special governance activities to combat fraud and insurance fraud, achieving full coverage of supervision and inspection of designated medical institutions and retail pharmacies nationwide, and publicizing typical cases of fraud and insurance fraud." In fact, this kind of "sitting together" punishment has caused many disputes It is believed that one of the stores in a chain drugstore has been terminated the medical insurance agreement due to violation of regulations, and the stores in the whole region have to bear "joint liability" and also have to be terminated the medical insurance agreement For small chains, the blow is devastating This approach is also unfair, but this document is only a draft for comments Whether this clause can be adopted remains to be seen >>Internet drugstores can rely on their physical drugstores to apply for fixed points in the [application scope] item, and the "opinion draft" makes it clear that retail drugstores that have obtained the "drug business license" can voluntarily apply for medical security fixed points Internet drugstores, retail drugstores that have drug network sales business or carry out drug network sales through the third-party platform of drug network transactions, shall apply for fixed points relying on their physical drugstores This may greatly limit the possible scale of online drug sales.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.